Due to the recent focus on GLP-1 and its analogues for treatment, our present study suggests a new possibility for Oxt to induce internal intra-islet GLP-1 secretion, which may enhance insulin secretion and thus hold potential for diabetes treatment. The gene discussed is INS; the disease is diabetes mellitus.